This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

This Beaten-Down Stock Is Ready to Rebound

DELAFIELD, Wis. (Stockpickr) -- The market experienced heavy selling pressure on Thursday, with the Dow Jones Industrial Average dropping 160 points and the S&P 500 sliding lower by 17 points.

>>5 Stocks Under $10 Set to Soar

Despite that bearish action, one chart pattern continues to show promise: beaten-down stocks that have entered extremely oversold territory. Stocks that share these characteristics have been working in this tough environment. Take, for example, biopharmaceutical stock Celldex Therapeutics (CLDX), which dropped from its February high of $33.33 a share to its May low of $10.76 a share. This stock has exploded higher over the last few trading sessions, with shares ripping from $10.76 to Wednesday's intraday high of $15.97 a share.

Another great example is intellectual property player Spherix (SPEX), which the bears pressured lower from its January high of $10.40 a share to its recent low of $1.19 a share. Shares of SPEX finally saw a respite to the selling pressure this week, when the stock rebounded off that $1.19 low and exploded higher to its intraday high on Wednesday of $1.94 a share.

The bulls finally had enough with the selling in both SPEX and CLDX, which had pushed these stocks into extremely oversold territory. Once stocks like SPEX and CLDX become extremely oversold, even the shorts know it's time to cover and lock in their profits and buy these stocks back to play the inevitable rebound trades.

>>5 Stocks Insiders Love Right Now

This is a theme that's been playing out over the last couple of weeks. Traders are coming after the beaten-down extremely oversold stocks and buying them in anticipation of rebound trades. The days of buying momentum names that show continuation moves to the upside are over for now. The new trend in the market is to buy the stocks with the worst charts that are beaten-down to depressed levels. This strategy doesn't appear to be ending anytime soon.

Part of the reason this strategy is working is that the shorts have been successful in knocking down a ton of momentum names, small-cap plays and tech and biotechnology stocks to extremely oversold readings in very short timeframes. This has created a situation where it doesn't take much buying pressure from the remaining bulls to spike these beaten-down names dramatically higher since most of the natural sellers of these stocks have been cleared out during their sharp falls.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs